Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Boursereau, R.
7  Ergebnisse:
Personensuche X
?
1

Abolition of the NLRP3 inflammasome improves the dystrophic..:

Boursereau, R. ; Abou-Samra, M. ; Lecompte, S...
Neuromuscular Disorders.  27 (2017)  - p. S98 , 2017
Link: https://doi.org/10.1016/..
 
?
2

Skeletal muscle secretome in Duchenne muscular dystrophy: a..:

Lecompte, S. ; Abou-Samra, M. ; Boursereau, R...
Cellular and Molecular Life Sciences.  74 (2017)  13 - p. 2487-2501 , 2017
Link: https://doi.org/10.1007/..
 
?
3

Potential therapeutic action of adiponectin in Duchenne mus..:

Abou-Samra, M. ; Boursereau, R. ; Noel, L..
Neuromuscular Disorders.  26 (2016)  - p. S129 , 2016
Link: https://doi.org/10.1016/..
 
?
4

Adiponectin hinders the NLRP3 inflammasome in a murine mode..:

Boursereau, R. ; Abou-Samra, M. ; Lecompte, S...
Neuromuscular Disorders.  26 (2016)  - p. S153 , 2016
Link: https://doi.org/10.1016/..
 
?
5

Therapeutic potential of adiponectin and adipoRon in Duchen..:

Lecompte, S. ; Abou-Samra, M. ; Boursereau, R...
Neuromuscular Disorders.  25 (2015)  - p. S261 , 2015
Link: https://doi.org/10.1016/..
 
?
6

O40 De nouvelles cibles pour contrôler l'inflammation dans ..:

Boursereau, R. ; Abou Samra, M. ; Deprez, C...
Diabetes & Metabolism.  41 (2015)  - p. A11-A12 , 2015
Link: https://doi.org/10.1016/..
 
?
7

New targets to control skeletal muscle inflammation: MicroR..:

Boursereau, R. ; Abou-Samra, M. ; Lecompte, S....
Neuromuscular Disorders.  25 (2015)  - p. S309-S310 , 2015
Link: https://doi.org/10.1016/..
 
1-7